Paternal epigenome influences offspring's susceptibility to dysmetabolism
Differently from the plethora of pre- and post-conceptional roles exploited by mothers during embryo development, the contribution of sperm cells has been thought for decades to be exclusively genetic. According to genetic inheritance theory, paternal contribution to the phenotypic variability of an individual (including its susceptibility to disease) had to be ascribed exclusively to the genetic sequence of paternally inherited allelic variants and to their interactions with those maternally inherited1. Nowadays, it is clear that alleles are not the only genetic messages transmitted by the father to his offspring during fertilization and that, instead, a multitude of epigenetic signals contribute to paternal inheritance2,3,4. Epigenetic signals so far identified include: (1) methyl groups covalently added to cytosines of the parental genome5,6,7, (2) post-translational modifications (acetylation, methylation) of histones associated with sperm chromosomes and delivered to the oocytes8, (3) the 3D organization of paternal chromosomes leading to intrachromosomal interaction (also known as topologically association domains, TAD) persisting in the zygote9,10, and (4) regulatory RNA molecules (miRNAs, tRNA-derived fragments, and piwi-interacting RNAs)11,12 as well as rRNAs13 and tRNAs14 released from sperm into oocyte during fertilization.
The paternal epigenome is an important vehicle of information for the progeny. Paternal information will influence the zygote, the embryo during its development, and, after birth, offspring's propensity to dysmetabolism and diseases. This non-Mendelian inheritance (referred to as intergenerational or transgenerational depending on whether it affects one or multiple consecutive generations), is considered by many authors one of the undercover contributing factors responsible for the drastic increase in dysmetabolic diseases occurring in developed Western countries15. Indeed, according to the PoHaD (Paternal Origin of Health and Disease) and DoHaD (Developmental Origin of Health and Disease) theories, the parental epigenetic contribution is one of the factors predisposing offspring to develop diabetes, obesity, and cardiovascular diseases in their adulthood16,17. Interestingly, the parental epigenome is exceptionally susceptible to environmental stimuli and can be influenced by metabolic conditions (such as drug use, dietary habits, and metabolic fitness)18 as well as strictly environmental parameters (such as exposure to pollutants, social relationships, and mental and relational stress)5,11. Each of the abovementioned stimuli can thus alter the epigenomes of germinal cells (sperm and oocytes) and influence future generations.
High-fat diet (HFD) consumption represents one of the most extensively studied environmental stimuli capable of altering paternal epigenome and leading to deleterious messages delivered to offspring19. This stimulus affects offspring phenotype (up to the third generation), who often display a greater propensity to develop dysmetabolism, regardless of their caloric intake. Offspring from father consuming HFD manifest growth retard, glucose intolerance, and insulin resistance in both mice and rats20,21. In humans, epigenetic inheritance has primarily been studied in generations born during and immediately after periods of famine or overfeeding22. In the Överkalix cohort, the food availability of paternal grandparents during their slow growth period was correlated with overall mortality risk, cardiovascular diseases, BMI, waist circumference, and fat mass of their grandchildren23. Recently, evidence of paternal intergenerational transmission has been confirmed in other cohorts24.
Paternal metabolites involved in intergenerational inheritance
Despite clinical and epidemiological evidence, the molecular details of paternal intergenerational inheritance remain unclear. At first, the identification of all molecular transducers of epigenetic information is still to be completed. Scientific evidence suggests that the nucleic component of spermatozoa, by itself, cannot explain the complexity of the intergeneration inheritance. Variations in DNA methylation have been indeed measured in the spermatozoa of mice and rats fed HFD, but in such a low percentage of the sperm population that this cannot account for the high penetrance of the dysmetabolic phenotype observed in the offspring25. On the other hand, the pool of signaling RNAs transferred from sperm to oocytes has a very short half-life and, although capable of influencing zygotic gene expression, seems unlikely to be maintained at effective concentrations post-fertilization, in the zygote in day-2, day-3 embryos, in morulae and in blastocysts. Thus, it seems evident that new molecular determinants must be involved in the intergenerational inheritance mechanism.
Along with nucleic acids, the sperm also contributes metabolomic components to the zygote, such as lipids, carbohydrates, and amino acids26,27,28,29. These metabolites, particularly those endowed with modulatory activities, could influence zygotic gene expression and embryonic development and thus might act as epigenetic signals30. Furthermore, similarly to nucleic acids, the concentration and the relative abundance of these metabolites in sperm can be influenced by environmental conditions experienced by the father and thus represent vehicles of information for the offspring28,30,31,32,33,34. Indeed, the sperm metabolome of mature spermatozoa has been shown to depend on the father's health status and be influenced by environmental factors such as diet, physical exercise, toxic substances, and endocrine disruptors.
Understanding the role of sperm metabolites in embryonic development is complicated by several technical limitations: (1) the size difference between the sperm and the oocyte, which results in a minimal metabolic mass contribution of the sperm for the zygote, and (2) the several metabolomic variations the sperm undergoes during its stages of production (spermatogenesis), epididymal maturation, ejaculation, and fusion with the oocyte.
Fluctuation of sperm metabolome during sperm maturation
In mammals, spermatozoa are produced in the testis through spermatogenesis, a spermatogonial stem cell-dependent process by which committed spermatogonia develop into primary spermatocytes that enter meiosis and produce round haploid spermatids. Morphogenesis of these cells into spermatozoa occurs through spermiogenesis, a massive morpho-functional remodeling of spermatids, from round cells to elongated/condensed/highly-specialized cells, corresponding to the last phase of spermatogenesis. However, the resulting spermatozoa are immotile and not yet capable of fertilization35. After spermiation, as spermatozoa are released from the rete testis into the epididymis, sperm cells interact with epithelial epididymal cells and engage with proteins and exosomal vesicles secreted by these cells (epididymosomes, rich in sphingomyelin and arachidonic acid). Passage through the epididymis enables the sperm to reach full maturity and, even if maintained in a pre-capacitated state, they acquire competence for motility36. During epididymal transit, the sperm membrane becomes more negatively charged and enriched in sphingomyelin. The sperm membrane becomes as well more fluid due to a progressive reduction in cholesterol and a concomitant increase in polyunsaturated fatty acids (mainly arachidonic, docosapentaenoic, and docosahexaenoic acids). Post-ejaculation, in the female genital tract, seminal fluid proteins and albumin promote sperm capacitation by promoting hyperpolarization and calcium influx to activate sperm motility. Capacitated sperms' plasma membrane presents further increased fluidity, low cholesterol-to-phospholipid ratio, and reduced sialic acid, GM1 ganglioside, and triglycerides content31,37.
Before encountering the oocyte, the sperm undergoes the acrosome reaction, a fusion of the acrosome (a Golgi-derived membranous organelle that covers the anterior part of the sperm nucleus and is formed during spermiogensis) with the sperm plasma membrane, that facilitates sperm plasma membrane reorganization and competence to penetrate of the zona pellucida (ZP), a matrix of glycoproteins surrounding the oocyte35,38. As the final step, hemifusion between the sperm and oocyte membrane, promoted by sperm proteins IZUMO1, SPACA6, and TMEM9539, results in the incorporation of sperm lipids into the oocyte membranes and the transfer of the nucleic and metabolic content into the oocyte.
Rationale of the procedure
The aim of this procedure is to identify metabolites transported by the sperm and transferred into the oocyte at fertilization (Figure 1). To distinguish between sperm- and oocyte-derived metabolites in the zygote, sperms are labeled with Deuterium (2H, a hydrogen isotope) or 13C (a carbon isotope) using in vivo metabolic labeling with Deuterium Oxide, 2H2O40, or uniformly labeled U13C Glucose41. Isotope-labeled male mice are then mated with unlabeled females to ultimately collect zygotes, morulae, and blastocysts. Early-stage embryos are processed to extract (1) polar, (2) non-polar metabolites, and (3) sterols. Metabolomes are then analyzed using mass spectrometry techniques. Isotopically-labeled (paternal) metabolites will be identified and distinguished from non-labeled (maternal) ones, unequivocally demonstrating their paternal origin.